Investor Relations

Four individuals wearing formal black suits and a woman in a black shirt with the word 'Mortician' on it, standing serious against a plain light-colored background.

The Problem

Prep‑room workflows are physically demanding, staff‑intensive, and time‑sensitive. Many funeral homes rely on improvised setups that increase strain, slow preparation, and elevate risk of injury.

  • Company: Fanprobe LLC (Virginia, USA)

  • Flagship: Mortuary Balancing Bar™ (MBB‑2508), patent‑pending

  • Stage: Pre‑revenue; production ramp in progress

  • Model: Product margin + accessories + software/services

  • Contact: invest@fanprobe.com · (888) 434‑4420

Close-up of an incandescent light bulb held in front of a glowing, orange-toned light source in the background.

Our Solution

Mortuary Balancing Bar™ functions like an extra set of hands—stabilizing and positioning with control, reducing strain, and improving throughput. Built from medical‑grade materials, designed for repeatable, hygienic use, and optimized for tight prep‑room spaces.

  • Safer, more ergonomic handling

  • Faster, more consistent prep times

  • Fewer staff required for key positioning steps

  • Durable, cleanable construction

  • Operational pressure on funeral homes to do more with less, without compromising dignity.

Bar chart titled 'Fanprobe TAM / SAM / SOM by Product Line' showing three product categories: Mortuary Balancing Bar™, Accessories & Consumables, and Software & Services. The chart has USD Billions on the y-axis and the product categories on the x-axis. It depicts three colored bars for each category representing TAM, SAM, and SOM, with TAM in gold, SAM in blue, and SOM in green.

The Market

  • Beachhead: U.S. funeral homes, pathology/education labs, and prep facilities.

  • Expansion: Training programs, regional distributors, international markets, adjacent care settings (with appropriate validation).

  • TAM: $6 B globally for this equipment segment

  • SAM: $1.2 B in the U.S.

  • SOM $20 M realistic 3–5 year capture with focused penetration.

  • Hardware — Mortuary Balancing Bar + Patient Balancing Bar

Based on 4k reviews

Rated

A person holding a clear light bulb against a colorful pastel sky.

Go-to-Market Strategy

  • Distributor-Led Sales:
    Leverage regional funeral service networks and supply distributors to expand reach quickly and reduce direct fulfillment costs.

  • Direct Pre-Order Channel:
    Enable direct online pre-orders through the website with education discounts and student validation to drive early adoption.

  • Academia & Training Partnerships:
    Partner with mortuary science programs, training centers, and accreditation bodies to embed the product into professional education and habits.

  • Evidence Marketing:
    Build trust through data-driven proof — publish measurable case studies showing time and strain reduction, along with peer and instructor testimonials.

Investor FAQs

  • Yes. We welcome direct conversations with serious investors. Please email invest@fanprobe.com to schedule a call or meeting with Kristopher Mickens.

  • All investors will receive quarterly email updates and milestone reports. You may also be invited to investor calls or early product previews, depending on your level of participation.

  • Fanprobe LLC is a U.S.-based limited liability company registered in the Commonwealth of Virginia. It is structured as a parent company that owns and develops individual product lines such as the Mortuary Balancing Bar, SuitRunner, and iD.Path.

  • Fanprobe is in the pre-revenue phase. Manufacturing of the Mortuary Balancing Bar is underway, and we anticipate revenue through direct pre-sales and distributor orders following product launch.

    • Scale U.S. distribution of the Mortuary Balancing Bar

    • Launch 2–3 additional products within the next 18–24 months

    • Expand into international markets

    • Establish strategic partnerships with funeral homes and supply distributors

    • Build a vertically integrated product ecosystem for the mortuary industry

Legal Note

This page is for informational purposes only and does not constitute an offer to sell or a solicitation to buy any securities. Any offering will be made only to accredited investors via definitive documentation (e.g., SAFE, convertible note, or other agreement) and in compliance with applicable laws.